Showing results (611-620 of 638) with videos related to

Sort By:
Pageof 64
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2018
Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 SignalingAdrián González-González, Esperanza Muñoz-Muela, Juan A Marchal, et al.
JCI Insight|October 26, 2016
Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapyLingegowda S Mangala, Hongyu Wang, Dahai Jiang, et al.
Journal of the National Cancer Institute|January 29, 2016
Role of Increased n-acetylaspartate Levels in CancerBehrouz Zand, Rebecca A Previs, Niki M Zacharias, et al.
Cell Reports|April 19, 2018
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast CancerPeijing Zhang, Zhenna Xiao, Shouyu Wang, et al.
Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.
The Journal of Clinical Investigation|April 16, 2013
ATP11B mediates platinum resistance in ovarian cancerMyrthala Moreno-Smith, J B Halder, Paul S Meltzer, et al.
Vascular|March 23, 2024
Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous diseaseEthan Moore, Max V Wohlauer, James Dorosh, et al.
Cancer Cell|August 2, 2016
Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic NicheFabrizio Miranda, David Mannion, Shujuan Liu, et al.
The Journal of Clinical Investigation|June 1, 2023
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune responseMihnea P Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, et al.
Pageof 64